243 related articles for article (PubMed ID: 15877529)
21. Targeting poly (ADP) ribose polymerase I (PARP-1) and PARP-1 interacting proteins for cancer treatment.
Sakamoto-Hojo ET; Balajee AS
Anticancer Agents Med Chem; 2008 May; 8(4):402-16. PubMed ID: 18473725
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation.
Wang X; Ohnishi K; Takahashi A; Ohnishi T
Oncogene; 1998 Dec; 17(22):2819-25. PubMed ID: 9879988
[TBL] [Abstract][Full Text] [Related]
23. A stronger DNA damage-induced G2 checkpoint due to over-activated CHK1 in the absence of PARP-1.
Lu HR; Wang X; Wang Y
Cell Cycle; 2006 Oct; 5(20):2364-70. PubMed ID: 17102615
[TBL] [Abstract][Full Text] [Related]
24. Emerging cancer therapeutic opportunities target DNA-repair systems.
Ding J; Miao ZH; Meng LH; Geng MY
Trends Pharmacol Sci; 2006 Jun; 27(6):338-44. PubMed ID: 16697054
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribose)polymerase (PARP) inhibitors: from bench to bedside.
Plummer R
Clin Oncol (R Coll Radiol); 2014 May; 26(5):250-6. PubMed ID: 24602564
[TBL] [Abstract][Full Text] [Related]
26. Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.
Ahel I; Ahel D; Matsusaka T; Clark AJ; Pines J; Boulton SJ; West SC
Nature; 2008 Jan; 451(7174):81-5. PubMed ID: 18172500
[TBL] [Abstract][Full Text] [Related]
27. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
28. Strategies for targeting the DNA damage response for cancer therapeutics.
Zhang D; Wang HB; Brinkman KL; Han SX; Xu B
Chin J Cancer; 2012 Aug; 31(8):359-63. PubMed ID: 22704491
[TBL] [Abstract][Full Text] [Related]
29. PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cells.
Booth L; Cruickshanks N; Ridder T; Dai Y; Grant S; Dent P
Cancer Biol Ther; 2013 May; 14(5):458-65. PubMed ID: 23917378
[TBL] [Abstract][Full Text] [Related]
30. Poly(ADP-ribose) polymerase inhibitors in cancer treatment: a clinical perspective.
Sandhu SK; Yap TA; de Bono JS
Eur J Cancer; 2010 Jan; 46(1):9-20. PubMed ID: 19926276
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells.
Koniaras K; Cuddihy AR; Christopoulos H; Hogg A; O'Connell MJ
Oncogene; 2001 Nov; 20(51):7453-63. PubMed ID: 11709716
[TBL] [Abstract][Full Text] [Related]
32. Silencing of poly(ADP-ribose) glycohydrolase sensitizes lung cancer cells to radiation through the abrogation of DNA damage checkpoint.
Nakadate Y; Kodera Y; Kitamura Y; Tachibana T; Tamura T; Koizumi F
Biochem Biophys Res Commun; 2013 Nov; 441(4):793-8. PubMed ID: 24211580
[TBL] [Abstract][Full Text] [Related]
33. Interaction of DNA-dependent protein kinase and poly(ADP-ribose) polymerase with radiation-induced DNA strand breaks.
Weinfeld M; Chaudhry MA; D'Amours D; Pelletier JD; Poirier GG; Povirk LF; Lees-Miller SP
Radiat Res; 1997 Jul; 148(1):22-8. PubMed ID: 9216614
[TBL] [Abstract][Full Text] [Related]
34. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death.
Nome RV; Bratland A; Harman G; Fodstad O; Andersson Y; Ree AH
Mol Cancer Ther; 2005 Aug; 4(8):1231-8. PubMed ID: 16093439
[TBL] [Abstract][Full Text] [Related]
35. Dovitinib induces mitotic defects and activates the G2 DNA damage checkpoint.
Man WY; Mak JP; Poon RY
J Cell Mol Med; 2014 Jan; 18(1):143-55. PubMed ID: 24238094
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage.
Bacalini MG; Di Lonardo D; Catizone A; Ciccarone F; Bruno T; Zampieri M; Guastafierro T; Calabrese R; Fanciulli M; Passananti C; Caiafa P; Reale A
DNA Repair (Amst); 2011 Apr; 10(4):380-9. PubMed ID: 21317046
[TBL] [Abstract][Full Text] [Related]
37. FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-kinase dependent activation of poly(ADP-ribose) polymerase.
Caldini R; Barletta E; Del Rosso M; Giovannelli L; Chevanne M
J Cell Physiol; 2005 Jan; 202(1):125-34. PubMed ID: 15389540
[TBL] [Abstract][Full Text] [Related]
38. CHEK again: revisiting the development of CHK1 inhibitors for cancer therapy.
McNeely S; Beckmann R; Bence Lin AK
Pharmacol Ther; 2014 Apr; 142(1):1-10. PubMed ID: 24140082
[TBL] [Abstract][Full Text] [Related]
39. DNA damage checkpoint control in cells exposed to ionizing radiation.
Iliakis G; Wang Y; Guan J; Wang H
Oncogene; 2003 Sep; 22(37):5834-47. PubMed ID: 12947390
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.
Liu X; Guo Y; Li Y; Jiang Y; Chubb S; Azuma A; Huang P; Matsuda A; Hittelman W; Plunkett W
Cancer Res; 2005 Aug; 65(15):6874-81. PubMed ID: 16061671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
